MLTX CLASS REMINDER: MoonLake Immunotherapeutics Investors are Reminded to Contact BFA Law before the Imminent December 15 Securities Class Action Deadline
New York, New York–(Newsfile Corp. – November 28, 2025) – Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to […]